NCT00747123
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigative Site Moscow, Russia
- Investigative Site Saint Petersburg, Russia
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT02375555
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT01943851
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +19 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Philadelphia, Pennsylvania, United States
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- Centrum für Hämatologie und Onkologie Bethanien Frankfurt am Main, Hesse, Germany
Completed
MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma
NCT04798586
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Nagoya City University Hospital Nagoya, Aichi-ken, Japan
- Japanese Red Cross Medical Center Shibuya-ku, Tokyo, Japan
NCT02939183
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Research Site West Hollywood, California, United States
- Research Site Tampa, Florida, United States
- Research Site Atlanta, Georgia, United States
- Research Site Chicago, Illinois, United States
NCT02892383
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Sygehus Sønderjylland Aabenraa, Denmark
- Aalborg University Hospital Aalborg, Denmark
- Aarhus University Hospital Aarhus, Denmark
- Rigshospitalet Copenhagen, Denmark
NCT02616640
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Local Institution - 102 Baltimore, Maryland, United States
- Local Institution - 114 Boston, Massachusetts, United States
- Local Institution - 108 Boston, Massachusetts, United States
- Local Institution - 115 Boston, Massachusetts, United States
Completed
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
NCT01827137
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +27 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
NCT02633059
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chromosome 17 deletion, +15 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States